Clinical trial
The Safety and Efficacy of Fecal Microbiota Transplant for Steroid-refractory Graft-versus-host Disease
NCT06938165 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Fecal Microbiota Transplant for Steroid-refractory Graft-versus-host Disease
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2020
- Completion date
- June 30, 2024
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gvhd